Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP379940.RAVA8-TxvQruTR3MrvaBZlhgCGV3vDkv23WknnEGjfqiI130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP379940.RAVA8-TxvQruTR3MrvaBZlhgCGV3vDkv23WknnEGjfqiI130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP379940.RAVA8-TxvQruTR3MrvaBZlhgCGV3vDkv23WknnEGjfqiI130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP379940.RAVA8-TxvQruTR3MrvaBZlhgCGV3vDkv23WknnEGjfqiI130_provenance.
- NP379940.RAVA8-TxvQruTR3MrvaBZlhgCGV3vDkv23WknnEGjfqiI130_assertion description "[Current HER2-directed therapies confer limited clinical benefits and most patients experience progressive disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP379940.RAVA8-TxvQruTR3MrvaBZlhgCGV3vDkv23WknnEGjfqiI130_provenance.
- NP379940.RAVA8-TxvQruTR3MrvaBZlhgCGV3vDkv23WknnEGjfqiI130_assertion evidence source_evidence_literature NP379940.RAVA8-TxvQruTR3MrvaBZlhgCGV3vDkv23WknnEGjfqiI130_provenance.
- NP379940.RAVA8-TxvQruTR3MrvaBZlhgCGV3vDkv23WknnEGjfqiI130_assertion SIO_000772 20179231 NP379940.RAVA8-TxvQruTR3MrvaBZlhgCGV3vDkv23WknnEGjfqiI130_provenance.
- NP379940.RAVA8-TxvQruTR3MrvaBZlhgCGV3vDkv23WknnEGjfqiI130_assertion wasDerivedFrom befree-20150227 NP379940.RAVA8-TxvQruTR3MrvaBZlhgCGV3vDkv23WknnEGjfqiI130_provenance.
- NP379940.RAVA8-TxvQruTR3MrvaBZlhgCGV3vDkv23WknnEGjfqiI130_assertion wasGeneratedBy ECO_0000203 NP379940.RAVA8-TxvQruTR3MrvaBZlhgCGV3vDkv23WknnEGjfqiI130_provenance.
- befree-20150227 importedOn "2015-02-27" NP379940.RAVA8-TxvQruTR3MrvaBZlhgCGV3vDkv23WknnEGjfqiI130_provenance.